Patricia Font

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group

Theresia M. Westers, Robin Ireland, Wolfgang Kern et al. · Leukemia · 2012 · 244 citations · Full text

Medicine, Hematology, Oncology +17

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes

Arjan A. van de Loosdrecht, Canan Alhan, Marie C. Béné et al. · Haematologica · 2009 · 238 citations · Full text

Medicine, Hematology, Pathology +16

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Leukemia · 2021 · 178 citations · Full text

Medicine, Hematology, Pharmacology +14

Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion–Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study

David P. Steensma, Pierre Fenaux, Koen Van Eygen et al. · Journal of Clinical Oncology · 2020 · 125 citations · Full text

Medicine, Hematology, Pharmacology +13

Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML)

David P. Steensma, Martin Wermke, Virginia M. Klimek et al. · Blood · 2019 · 89 citations

Medicine, Genetics, Hematology +14